Resmed (RMD) Total Current Liabilities (2010 - 2026)

Resmed's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• Quarterly Total Current Liabilities rose 43.67% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 43.67% YoY) and the FY2025 annual result came in at $1.0 billion, up 11.91% from the prior year.
• Total Current Liabilities was $1.4 billion for Q1 2026 at Resmed, up from $1.2 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $1.4 billion in Q1 2026 and bottomed at $667.3 million in Q1 2022.
• A 5-year average of $887.7 million and a median of $773.0 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities slipped 24.4% — and 2025, when it jumped 46.5%.
• Resmed's Total Current Liabilities stood at $732.7 million in 2022, then grew by 4.28% to $764.1 million in 2023, then climbed by 11.5% to $852.0 million in 2024, then surged by 46.5% to $1.2 billion in 2025, then advanced by 8.26% to $1.4 billion in 2026.
• Business Quant data shows RMD's Total Current Liabilities at $1.4 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.3 billion in Q3 2025.